Page last updated: 2024-10-28

idebenone and Allergic Encephalomyelitis

idebenone has been researched along with Allergic Encephalomyelitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"However, in experimental autoimmune encephalomyelitis, idebenone failed to affect disease incidence or onset when applied preventively, or to reduce disease severity when applied therapeutically."1.39The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse. ( Bros, H; Chanvillard, C; Dörr, J; Fiebiger, SM; Grobosch, T; Infante-Duarte, C; Janssen, A; Millward, JM; Paul, F, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiebiger, SM1
Bros, H1
Grobosch, T1
Janssen, A1
Chanvillard, C1
Paul, F1
Dörr, J1
Millward, JM1
Infante-Duarte, C1

Other Studies

1 other study available for idebenone and Allergic Encephalomyelitis

ArticleYear
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
    Journal of neuroimmunology, 2013, Sep-15, Volume: 262, Issue:1-2

    Topics: Animals; Antioxidants; Chronic Disease; Disease Models, Animal; Encephalomyelitis, Autoimmune, Exper

2013